SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-041679
Filing Date
2021-02-12
Accepted
2021-02-12 16:32:05
Documents
1
Group Members
CHART WESTCOTTIKARIAN HEALTHCARE FUND GP, L.P.IKARIAN HEALTHCARE MASTER FUND, L.P.NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d130776dsc13ga.htm SC 13G/A 107451
  Complete submission text file 0001193125-21-041679.txt   109171
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13G/A | Act: 34 | File No.: 005-89153 | Film No.: 21628227
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A